Global Orexin Receptor Antagonists Market Research Report 2023

Orexin Receptor Antagonists Market

Orexin receptor antagonists are the type of therapeutics used in the treatment of sleep disorders, characterized by difficulties or problems with sleep onset. It either bind or inhibits the action of orexin receptor. Orexin plays a vital role in the sleep–wake cycle through a complex interplay between the monoaminergic/cholinergic (wake-promoting) and gamma-aminobutyric acidergic (sleep-promoting) neuronal systems.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Orexin Receptor Antagonists market research.

Increased prevalence of various sleep disorders such as insomnia and parasomnias, along with rising incidence of depression and other distressing disorders are major factors driving insomnia. Expanding the Global Insomnia Market. Sleep disturbance is a common symptom of depression. For example, according to the World Health Organization (WHO), approximately 280 million people worldwide suffer from depression. Hence, the surge in the prevalence of psychotic depression across the world has led to the expansion of the insomnia market. In addition, long-term use of a drug to treat a chronic condition may cause certain adverse effects, some of which are thought to impair a patient's ability to get a good night's sleep. This means that the expansion of the market is driven by the increasing prevalence of chronic diseases such as cancer.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Orexin Receptor Antagonists market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Orexin Receptor Antagonists Market Report

1.1 Product Overview and Scope of Orexin Receptor Antagonists

1.2 Orexin Receptor Antagonists Segment by Type

1.2.1 Global Orexin Receptor Antagonists Market Value Comparison by Type (2023-2029)

1.2.2 Oral

1.2.3 Parenteral

1.3 Orexin Receptor Antagonists Segment by Application

1.3.1 Global Orexin Receptor Antagonists Market Value by Application: (2023-2029)

1.3.2 Insomnia

1.3.3 Anxious

1.3.4 Other

1.4 Global Orexin Receptor Antagonists Market Size Estimates and Forecasts

1.4.1 Global Orexin Receptor Antagonists Revenue 2018-2029

1.4.2 Global Orexin Receptor Antagonists Sales 2018-2029

1.4.3 Global Orexin Receptor Antagonists Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Orexin Receptor Antagonists Sales Market Share by Manufacturers (2018-2023)

2.2 Global Orexin Receptor Antagonists Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Orexin Receptor Antagonists Average Price by Manufacturers (2018-2023)

2.4 Global Orexin Receptor Antagonists Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Orexin Receptor Antagonists, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Orexin Receptor Antagonists, Product Type & Application

2.7 Orexin Receptor Antagonists Market Competitive Situation and Trends

2.7.1 Orexin Receptor Antagonists Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Orexin Receptor Antagonists Players Market Share by Revenue

2.7.3 Global Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Orexin Receptor Antagonists Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Orexin Receptor Antagonists Global Orexin Receptor Antagonists Sales by Region: 2018-2029

3.2.1 Global Orexin Receptor Antagonists Sales by Region: 2018-2023

3.2.2 Global Orexin Receptor Antagonists Sales by Region: 2024-2029

3.3 Global Orexin Receptor Antagonists Global Orexin Receptor Antagonists Revenue by Region: 2018-2029

3.3.1 Global Orexin Receptor Antagonists Revenue by Region: 2018-2023

3.3.2 Global Orexin Receptor Antagonists Revenue by Region: 2024-2029

3.4 North America Orexin Receptor Antagonists Market Facts & Figures by Country

3.4.1 North America Orexin Receptor Antagonists Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Orexin Receptor Antagonists Sales by Country (2018-2029)

3.4.3 North America Orexin Receptor Antagonists Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Orexin Receptor Antagonists Market Facts & Figures by Country

3.5.1 Europe Orexin Receptor Antagonists Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Orexin Receptor Antagonists Sales by Country (2018-2029)

3.5.3 Europe Orexin Receptor Antagonists Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Orexin Receptor Antagonists Market Facts & Figures by Country

3.6.1 Asia Pacific Orexin Receptor Antagonists Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Orexin Receptor Antagonists Sales by Country (2018-2029)

3.6.3 Asia Pacific Orexin Receptor Antagonists Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Orexin Receptor Antagonists Market Facts & Figures by Country

3.7.1 Latin America Orexin Receptor Antagonists Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Orexin Receptor Antagonists Sales by Country (2018-2029)

3.7.3 Latin America Orexin Receptor Antagonists Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Orexin Receptor Antagonists Market Facts & Figures by Country

3.8.1 Middle East and Africa Orexin Receptor Antagonists Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Orexin Receptor Antagonists Sales by Country (2018-2029)

3.8.3 Middle East and Africa Orexin Receptor Antagonists Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Orexin Receptor Antagonists Sales by Type (2018-2029)

4.1.1 Global Orexin Receptor Antagonists Sales by Type (2018-2023)

4.1.2 Global Orexin Receptor Antagonists Sales by Type (2024-2029)

4.1.3 Global Orexin Receptor Antagonists Sales Market Share by Type (2018-2029)

4.2 Global Orexin Receptor Antagonists Revenue by Type (2018-2029)

4.2.1 Global Orexin Receptor Antagonists Revenue by Type (2018-2023)

4.2.2 Global Orexin Receptor Antagonists Revenue by Type (2024-2029)

4.2.3 Global Orexin Receptor Antagonists Revenue Market Share by Type (2018-2029)

4.3 Global Orexin Receptor Antagonists Price by Type (2018-2029)

5.1 Global Orexin Receptor Antagonists Sales by Application (2018-2029)

5.1.1 Global Orexin Receptor Antagonists Sales by Application (2018-2023)

5.1.2 Global Orexin Receptor Antagonists Sales by Application (2024-2029)

5.1.3 Global Orexin Receptor Antagonists Sales Market Share by Application (2018-2029)

5.2 Global Orexin Receptor Antagonists Revenue by Application (2018-2029)

5.2.1 Global Orexin Receptor Antagonists Revenue by Application (2018-2023)

5.2.2 Global Orexin Receptor Antagonists Revenue by Application (2024-2029)

5.2.3 Global Orexin Receptor Antagonists Revenue Market Share by Application (2018-2029)

5.3 Global Orexin Receptor Antagonists Price by Application (2018-2029)

6.1 Eisai Co., Ltd

6.1.1 Eisai Co., Ltd Corporation Information

6.1.2 Eisai Co., Ltd Description and Business Overview

6.1.3 Eisai Co., Ltd Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Eisai Co., Ltd Orexin Receptor Antagonists Product Portfolio

6.1.5 Eisai Co., Ltd Recent Developments/Updates

6.2 Sun Pharmaceutical Industries Ltd

6.2.1 Sun Pharmaceutical Industries Ltd Corporation Information

6.2.2 Sun Pharmaceutical Industries Ltd Description and Business Overview

6.2.3 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Portfolio

6.2.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates

6.3 Novartis AG

6.3.1 Novartis AG Corporation Information

6.3.2 Novartis AG Description and Business Overview

6.3.3 Novartis AG Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Novartis AG Orexin Receptor Antagonists Product Portfolio

6.3.5 Novartis AG Recent Developments/Updates

6.4 Endo Pharmaceuticals plc

6.4.1 Endo Pharmaceuticals plc Corporation Information

6.4.2 Endo Pharmaceuticals plc Description and Business Overview

6.4.3 Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Endo Pharmaceuticals plc Orexin Receptor Antagonists Product Portfolio

6.4.5 Endo Pharmaceuticals plc Recent Developments/Updates

6.5 Mylan NV

6.5.1 Mylan NV Corporation Information

6.5.2 Mylan NV Description and Business Overview

6.5.3 Mylan NV Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Mylan NV Orexin Receptor Antagonists Product Portfolio

6.5.5 Mylan NV Recent Developments/Updates

6.6 Cereve Inc.

6.6.1 Cereve Inc. Corporation Information

6.6.2 Cereve Inc. Description and Business Overview

6.6.3 Cereve Inc. Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Cereve Inc. Orexin Receptor Antagonists Product Portfolio

6.6.5 Cereve Inc. Recent Developments/Updates

6.7 Teva Pharmaceutical Industries Ltd

6.6.1 Teva Pharmaceutical Industries Ltd Corporation Information

6.6.2 Teva Pharmaceutical Industries Ltd Description and Business Overview

6.6.3 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product Portfolio

6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates

6.8 Amneal Pharmaceuticals Inc

6.8.1 Amneal Pharmaceuticals Inc Corporation Information

6.8.2 Amneal Pharmaceuticals Inc Description and Business Overview

6.8.3 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product Portfolio

6.8.5 Amneal Pharmaceuticals Inc Recent Developments/Updates

6.9 Merck & Co.

6.9.1 Merck & Co. Corporation Information

6.9.2 Merck & Co. Description and Business Overview

6.9.3 Merck & Co. Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Merck & Co. Orexin Receptor Antagonists Product Portfolio

6.9.5 Merck & Co. Recent Developments/Updates

6.10 Sanofi

6.10.1 Sanofi Corporation Information

6.10.2 Sanofi Description and Business Overview

6.10.3 Sanofi Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Sanofi Orexin Receptor Antagonists Product Portfolio

6.10.5 Sanofi Recent Developments/Updates

6.11 Currax Pharmaceuticals LLC

6.11.1 Currax Pharmaceuticals LLC Corporation Information

6.11.2 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Description and Business Overview

6.11.3 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.11.4 Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product Portfolio

6.11.5 Currax Pharmaceuticals LLC Recent Developments/Updates

6.12 Pfizer Inc.

6.12.1 Pfizer Inc. Corporation Information

6.12.2 Pfizer Inc. Orexin Receptor Antagonists Description and Business Overview

6.12.3 Pfizer Inc. Orexin Receptor Antagonists Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Pfizer Inc. Orexin Receptor Antagonists Product Portfolio

6.12.5 Pfizer Inc. Recent Developments/Updates

7.1 Orexin Receptor Antagonists Industry Chain Analysis

7.2 Orexin Receptor Antagonists Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Orexin Receptor Antagonists Production Mode & Process

7.4 Orexin Receptor Antagonists Sales and Marketing

7.4.1 Orexin Receptor Antagonists Sales Channels

7.4.2 Orexin Receptor Antagonists Distributors

7.5 Orexin Receptor Antagonists Customers

8.1 Orexin Receptor Antagonists Industry Trends

8.2 Orexin Receptor Antagonists Market Drivers

8.3 Orexin Receptor Antagonists Market Challenges

8.4 Orexin Receptor Antagonists Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Orexin Receptor Antagonists Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Orexin Receptor Antagonists Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Orexin Receptor Antagonists Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Orexin Receptor Antagonists Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Orexin Receptor Antagonists Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Orexin Receptor Antagonists Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Orexin Receptor Antagonists Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Orexin Receptor Antagonists Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Orexin Receptor Antagonists, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Orexin Receptor Antagonists, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Orexin Receptor Antagonists, Product Type & Application

    Table 12. Global Key Manufacturers of Orexin Receptor Antagonists, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Orexin Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orexin Receptor Antagonists as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Orexin Receptor Antagonists Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Orexin Receptor Antagonists Sales by Region (2018-2023) & (K Units)

    Table 18. Global Orexin Receptor Antagonists Sales Market Share by Region (2018-2023)

    Table 19. Global Orexin Receptor Antagonists Sales by Region (2024-2029) & (K Units)

    Table 20. Global Orexin Receptor Antagonists Sales Market Share by Region (2024-2029)

    Table 21. Global Orexin Receptor Antagonists Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Orexin Receptor Antagonists Revenue Market Share by Region (2018-2023)

    Table 23. Global Orexin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Orexin Receptor Antagonists Revenue Market Share by Region (2024-2029)

    Table 25. North America Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Orexin Receptor Antagonists Sales by Country (2018-2023) & (K Units)

    Table 27. North America Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)

    Table 28. North America Orexin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Orexin Receptor Antagonists Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Orexin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Orexin Receptor Antagonists Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Orexin Receptor Antagonists Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Orexin Receptor Antagonists Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Orexin Receptor Antagonists Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Orexin Receptor Antagonists Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Orexin Receptor Antagonists Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Orexin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Orexin Receptor Antagonists Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Orexin Receptor Antagonists Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Orexin Receptor Antagonists Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Orexin Receptor Antagonists Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Orexin Receptor Antagonists Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Orexin Receptor Antagonists Sales (K Units) by Type (2018-2023)

    Table 51. Global Orexin Receptor Antagonists Sales (K Units) by Type (2024-2029)

    Table 52. Global Orexin Receptor Antagonists Sales Market Share by Type (2018-2023)

    Table 53. Global Orexin Receptor Antagonists Sales Market Share by Type (2024-2029)

    Table 54. Global Orexin Receptor Antagonists Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Orexin Receptor Antagonists Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Orexin Receptor Antagonists Revenue Market Share by Type (2018-2023)

    Table 57. Global Orexin Receptor Antagonists Revenue Market Share by Type (2024-2029)

    Table 58. Global Orexin Receptor Antagonists Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Orexin Receptor Antagonists Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Orexin Receptor Antagonists Sales (K Units) by Application (2018-2023)

    Table 61. Global Orexin Receptor Antagonists Sales (K Units) by Application (2024-2029)

    Table 62. Global Orexin Receptor Antagonists Sales Market Share by Application (2018-2023)

    Table 63. Global Orexin Receptor Antagonists Sales Market Share by Application (2024-2029)

    Table 64. Global Orexin Receptor Antagonists Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Orexin Receptor Antagonists Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Orexin Receptor Antagonists Revenue Market Share by Application (2018-2023)

    Table 67. Global Orexin Receptor Antagonists Revenue Market Share by Application (2024-2029)

    Table 68. Global Orexin Receptor Antagonists Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Orexin Receptor Antagonists Price (US$/Unit) by Application (2024-2029)

    Table 70. Eisai Co., Ltd Corporation Information

    Table 71. Eisai Co., Ltd Description and Business Overview

    Table 72. Eisai Co., Ltd Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Eisai Co., Ltd Orexin Receptor Antagonists Product

    Table 74. Eisai Co., Ltd Recent Developments/Updates

    Table 75. Sun Pharmaceutical Industries Ltd Corporation Information

    Table 76. Sun Pharmaceutical Industries Ltd Description and Business Overview

    Table 77. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Sun Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product

    Table 79. Sun Pharmaceutical Industries Ltd Recent Developments/Updates

    Table 80. Novartis AG Corporation Information

    Table 81. Novartis AG Description and Business Overview

    Table 82. Novartis AG Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Novartis AG Orexin Receptor Antagonists Product

    Table 84. Novartis AG Recent Developments/Updates

    Table 85. Endo Pharmaceuticals plc Corporation Information

    Table 86. Endo Pharmaceuticals plc Description and Business Overview

    Table 87. Endo Pharmaceuticals plc Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Endo Pharmaceuticals plc Orexin Receptor Antagonists Product

    Table 89. Endo Pharmaceuticals plc Recent Developments/Updates

    Table 90. Mylan NV Corporation Information

    Table 91. Mylan NV Description and Business Overview

    Table 92. Mylan NV Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Mylan NV Orexin Receptor Antagonists Product

    Table 94. Mylan NV Recent Developments/Updates

    Table 95. Cereve Inc. Corporation Information

    Table 96. Cereve Inc. Description and Business Overview

    Table 97. Cereve Inc. Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Cereve Inc. Orexin Receptor Antagonists Product

    Table 99. Cereve Inc. Recent Developments/Updates

    Table 100. Teva Pharmaceutical Industries Ltd Corporation Information

    Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview

    Table 102. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Teva Pharmaceutical Industries Ltd Orexin Receptor Antagonists Product

    Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates

    Table 105. Amneal Pharmaceuticals Inc Corporation Information

    Table 106. Amneal Pharmaceuticals Inc Description and Business Overview

    Table 107. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Amneal Pharmaceuticals Inc Orexin Receptor Antagonists Product

    Table 109. Amneal Pharmaceuticals Inc Recent Developments/Updates

    Table 110. Merck & Co. Corporation Information

    Table 111. Merck & Co. Description and Business Overview

    Table 112. Merck & Co. Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Merck & Co. Orexin Receptor Antagonists Product

    Table 114. Merck & Co. Recent Developments/Updates

    Table 115. Sanofi Corporation Information

    Table 116. Sanofi Description and Business Overview

    Table 117. Sanofi Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Sanofi Orexin Receptor Antagonists Product

    Table 119. Sanofi Recent Developments/Updates

    Table 120. Currax Pharmaceuticals LLC Corporation Information

    Table 121. Currax Pharmaceuticals LLC Description and Business Overview

    Table 122. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. Currax Pharmaceuticals LLC Orexin Receptor Antagonists Product

    Table 124. Currax Pharmaceuticals LLC Recent Developments/Updates

    Table 125. Pfizer Inc. Corporation Information

    Table 126. Pfizer Inc. Description and Business Overview

    Table 127. Pfizer Inc. Orexin Receptor Antagonists Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. Pfizer Inc. Orexin Receptor Antagonists Product

    Table 129. Pfizer Inc. Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Orexin Receptor Antagonists Distributors List

    Table 133. Orexin Receptor Antagonists Customers List

    Table 134. Orexin Receptor Antagonists Market Trends

    Table 135. Orexin Receptor Antagonists Market Drivers

    Table 136. Orexin Receptor Antagonists Market Challenges

    Table 137. Orexin Receptor Antagonists Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Orexin Receptor Antagonists

    Figure 2. Global Orexin Receptor Antagonists Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Orexin Receptor Antagonists Market Share by Type in 2022 & 2029

    Figure 4. Oral Product Picture

    Figure 5. Parenteral Product Picture

    Figure 6. Global Orexin Receptor Antagonists Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Orexin Receptor Antagonists Market Share by Application in 2022 & 2029

    Figure 8. Insomnia

    Figure 9. Anxious

    Figure 10. Other

    Figure 11. Global Orexin Receptor Antagonists Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 12. Global Orexin Receptor Antagonists Market Size (2018-2029) & (US$ Million)

    Figure 13. Global Orexin Receptor Antagonists Sales (2018-2029) & (K Units)

    Figure 14. Global Orexin Receptor Antagonists Average Price (US$/Unit) & (2018-2029)

    Figure 15. Orexin Receptor Antagonists Report Years Considered

    Figure 16. Orexin Receptor Antagonists Sales Share by Manufacturers in 2022

    Figure 17. Global Orexin Receptor Antagonists Revenue Share by Manufacturers in 2022

    Figure 18. The Global 5 and 10 Largest Orexin Receptor Antagonists Players: Market Share by Revenue in 2022

    Figure 19. Orexin Receptor Antagonists Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 20. Global Orexin Receptor Antagonists Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 21. North America Orexin Receptor Antagonists Sales Market Share by Country (2018-2029)

    Figure 22. North America Orexin Receptor Antagonists Revenue Market Share by Country (2018-2029)

    Figure 23. United States Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Canada Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 25. Europe Orexin Receptor Antagonists Sales Market Share by Country (2018-2029)

    Figure 26. Europe Orexin Receptor Antagonists Revenue Market Share by Country (2018-2029)

    Figure 27. Germany Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. France Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. U.K. Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Italy Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Russia Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Asia Pacific Orexin Receptor Antagonists Sales Market Share by Region (2018-2029)

    Figure 33. Asia Pacific Orexin Receptor Antagonists Revenue Market Share by Region (2018-2029)

    Figure 34. China Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Japan Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. South Korea Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. India Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. Australia Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. China Taiwan Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Southeast Asia Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Latin America Orexin Receptor Antagonists Sales Market Share by Country (2018-2029)

    Figure 42. Latin America Orexin Receptor Antagonists Revenue Market Share by Country (2018-2029)

    Figure 43. Mexico Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Brazil Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Argentina Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Middle East & Africa Orexin Receptor Antagonists Sales Market Share by Country (2018-2029)

    Figure 47. Middle East & Africa Orexin Receptor Antagonists Revenue Market Share by Country (2018-2029)

    Figure 48. Turkey Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Saudi Arabia Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. UAE Orexin Receptor Antagonists Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Global Sales Market Share of Orexin Receptor Antagonists by Type (2018-2029)

    Figure 52. Global Revenue Market Share of Orexin Receptor Antagonists by Type (2018-2029)

    Figure 53. Global Orexin Receptor Antagonists Price (US$/Unit) by Type (2018-2029)

    Figure 54. Global Sales Market Share of Orexin Receptor Antagonists by Application (2018-2029)

    Figure 55. Global Revenue Market Share of Orexin Receptor Antagonists by Application (2018-2029)

    Figure 56. Global Orexin Receptor Antagonists Price (US$/Unit) by Application (2018-2029)

    Figure 57. Orexin Receptor Antagonists Value Chain

    Figure 58. Orexin Receptor Antagonists Production Process

    Figure 59. Channels of Distribution (Direct Vs Distribution)

    Figure 60. Distributors Profiles

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed